<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33168089</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>09</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.</ArticleTitle><Pagination><StartPage>189</StartPage><MedlinePgn>189</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">189</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-020-01062-w</ELocationID><Abstract><AbstractText>Mutations in the PTEN-induced kinase 1 (PINK1) and Parkin RBR E3 ubiquitin-protein ligase (PARKIN) genes are associated with familial forms of Parkinson's disease (PD). PINK1, a protein kinase, and PARKIN, an E3 ubiquitin ligase, control the specific elimination of dysfunctional or superfluous mitochondria, thus fine-tuning mitochondrial network and preserving energy metabolism. PINK1 regulates PARKIN translocation in impaired mitochondria and drives their removal via selective autophagy, a process known as mitophagy. As knowledge obtained using different PINK1 and PARKIN transgenic animal models is being gathered, growing evidence supports the contribution of mitophagy impairment to several human pathologies, including PD and Alzheimer's diseases (AD). Therefore, therapeutic interventions aiming to modulate PINK1/PARKIN signalling might have the potential to treat these diseases. In this review, we will start by discussing how the interplay of PINK1 and PARKIN signalling helps mediate mitochondrial physiology. We will continue by debating the role of mitochondrial dysfunction in disorders such as amyotrophic lateral sclerosis, Alzheimer's, Huntington's and Parkinson's diseases, as well as eye diseases such as age-related macular degeneration and glaucoma, and the causative factors leading to PINK1/PARKIN-mediated neurodegeneration and neuroinflammation. Finally, we will discuss PINK1/PARKIN gene augmentation possibilities with a particular focus on AD, PD and glaucoma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Peter M J</ForeName><Initials>PMJ</Initials><AffiliationInfo><Affiliation>Jonas Children's Vision Care, and Bernard and Shirlee Brown Glaucoma Laboratory, Columbia Stem Cell Initiative, Departments of Ophthalmology, Pathology and Cell Biology, Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Paula I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Physiology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambr&#xf3;sio</LastName><ForeName>Ant&#xf3;nio Francisco</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>C Henrique</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0001-9776-5701</Identifier><AffiliationInfo><Affiliation>Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal. chalves@fmed.uc.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal. chalves@fmed.uc.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. chalves@fmed.uc.pt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal. chalves@fmed.uc.pt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.-</RegistryNumber><NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C433927">PTEN-induced putative kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055879" MajorTopicYN="N">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005901" MajorTopicYN="N">Glaucoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008268" MajorTopicYN="N">Macular Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="N">Mitophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011494" MajorTopicYN="N">Protein Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Mitophagy</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">PARKIN</Keyword><Keyword MajorTopicYN="N">PINK1</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>10</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33168089</ArticleId><ArticleId IdType="pmc">PMC7654589</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-01062-w</ArticleId><ArticleId IdType="pii">10.1186/s40478-020-01062-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Benda C. Ueber dier Spermatogenese de Verbebraten und h&#xf6;herer Evertebraten, II. Theil: die Histiogenese der Spermien. Arch Anat Physiol Arch Anat Physiol. 1898;73:393&#x2013;398.</Citation></Reference><Reference><Citation>Bernard G, Bellance N, James D, Parrone P, Fernandez H, Letellier T, et al. Mitochondrial bioenergetics and structural network organization. J Cell Sci. 2007;120(5):838&#x2013;848. doi: 10.1242/jcs.03381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.03381</ArticleId><ArticleId IdType="pubmed">17298981</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjostrand FS. Electron microscopy of mitochondria and cytoplasmic double membranes. Nature. 1953;171(4340):30&#x2013;32. doi: 10.1038/171030a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/171030a0</ArticleId><ArticleId IdType="pubmed">13025467</ArticleId></ArticleIdList></Reference><Reference><Citation>Palade GE. An electron microscope study of the mitochondrial structure. J Histochem Cytochem. 1953;1(4):188&#x2013;211. doi: 10.1177/1.4.188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1.4.188</ArticleId><ArticleId IdType="pubmed">13069686</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati S, Enriquez JA, Scorrano L. Mitochondrial cristae: where beauty meets functionality. Trends Biochem Sci. 2016;41(3):261&#x2013;273. doi: 10.1016/j.tibs.2016.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2016.01.001</ArticleId><ArticleId IdType="pubmed">26857402</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies KM, Strauss M, Daum B, Kief JH, Osiewacz HD, Rycovska A, et al. Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc Natl Acad Sci U S A. 2011;108(34):14121&#x2013;14126. doi: 10.1073/pnas.1103621108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103621108</ArticleId><ArticleId IdType="pmc">PMC3161574</ArticleId><ArticleId IdType="pubmed">21836051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees DM, Leslie AGW, Walker JE. The structure of the membrane extrinsic region of bovine ATP synthase. Proc Natl Acad Sci USA. 2009;106(51):21597&#x2013;21601. doi: 10.1073/pnas.0910365106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0910365106</ArticleId><ArticleId IdType="pmc">PMC2789756</ArticleId><ArticleId IdType="pubmed">19995987</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer PD, Chance B, Ernster L, Mitchell P, Racker E, Slater EC. Oxidative Phosphorylation and Photophosphorylation. Annu Rev Biochem. 1977;46(1):955&#x2013;966. doi: 10.1146/annurev.bi.46.070177.004515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.46.070177.004515</ArticleId><ArticleId IdType="pubmed">18361775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ac&#xed;n-P&#xe9;rez R, Fern&#xe1;ndez-Silva P, Peleato ML, P&#xe9;rez-Martos A, Enriquez JA. Respiratory Active Mitochondrial Supercomplexes. Mol Cell. 2008;32(4):529&#x2013;539. doi: 10.1016/j.molcel.2008.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2008.10.021</ArticleId><ArticleId IdType="pubmed">19026783</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20(7):745&#x2013;754. doi: 10.1038/s41556-018-0124-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0124-1</ArticleId><ArticleId IdType="pmc">PMC6541229</ArticleId><ArticleId IdType="pubmed">29950572</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun. 2017;482(3):426&#x2013;431. doi: 10.1016/j.bbrc.2016.11.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.11.088</ArticleId><ArticleId IdType="pubmed">28212726</ArticleId></ArticleIdList></Reference><Reference><Citation>Khacho M, Harris R, Slack RS. Mitochondria as central regulators of neural stem cell fate and cognitive function. Nat Rev Neurosci. 2019;20(1):34&#x2013;48. doi: 10.1038/s41583-018-0091-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0091-3</ArticleId><ArticleId IdType="pubmed">30464208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38(4):633&#x2013;643. doi: 10.1016/j.immuni.2013.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.04.005</ArticleId><ArticleId IdType="pmc">PMC3654249</ArticleId><ArticleId IdType="pubmed">23601682</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL, Kelly B, O&#x2019;Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017;18(5):488&#x2013;498. doi: 10.1038/ni.3704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3704</ArticleId><ArticleId IdType="pubmed">28418387</ArticleId></ArticleIdList></Reference><Reference><Citation>Angajala A, Lim S, Phillips JB, Kim JH, Yates C, You Z, et al. Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism. Front Immunol. 2018;9:1605. doi: 10.3389/fimmu.2018.01605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01605</ArticleId><ArticleId IdType="pmc">PMC6052888</ArticleId><ArticleId IdType="pubmed">30050539</ArticleId></ArticleIdList></Reference><Reference><Citation>Youle RJ, Van Der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337(6098):1062&#x2013;1065. doi: 10.1126/science.1219855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1219855</ArticleId><ArticleId IdType="pmc">PMC4762028</ArticleId><ArticleId IdType="pubmed">22936770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Vigi&#xe9; P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018;28(4):170&#x2013;185. doi: 10.1016/j.cub.2018.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.01.004</ArticleId><ArticleId IdType="pmc">PMC7255410</ArticleId><ArticleId IdType="pubmed">29462587</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y-T, Wu S-B, Lee W-L, Wei Y-H. Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases. Ann N Y Acad Sci. 2010;1201:147&#x2013;156. doi: 10.1111/j.1749-6632.2010.05631.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2010.05631.x</ArticleId><ArticleId IdType="pubmed">20649551</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol. 2010;5(1):297&#x2013;348. doi: 10.1146/annurev.pathol.4.110807.092314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathol.4.110807.092314</ArticleId><ArticleId IdType="pmc">PMC3245719</ArticleId><ArticleId IdType="pubmed">20078222</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco-Iborra S, Vila M, Perier C. Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson&#x2019;s disease and Huntington&#x2019;s disease. Front Neurosci. 2018;12:1&#x2013;25. doi: 10.3389/fnins.2018.00342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00342</ArticleId><ArticleId IdType="pmc">PMC5974257</ArticleId><ArticleId IdType="pubmed">29875626</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, et al. Mitochondrial fusion is required for mtdna stability in skeletal muscle and tolerance of mtDNA mutations. Cell. 2010;141(2):280&#x2013;289. doi: 10.1016/j.cell.2010.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.02.026</ArticleId><ArticleId IdType="pmc">PMC2876819</ArticleId><ArticleId IdType="pubmed">20403324</ArticleId></ArticleIdList></Reference><Reference><Citation>Shpilka T, Haynes CM. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat Rev Mol Cell Biol. 2018;19(2):109&#x2013;120. doi: 10.1038/nrm.2017.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.110</ArticleId><ArticleId IdType="pubmed">29165426</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadoro G, Corsetti V, Florenzano F, Atlante A, Bobba A, Nicolin V, et al. Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathway. Front Aging Neurosci. 2014;6:1&#x2013;18. doi: 10.3389/fnagi.2014.00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00018</ArticleId><ArticleId IdType="pmc">PMC3927396</ArticleId><ArticleId IdType="pubmed">24600391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura A, McLelland G, Fon EA, McBride HM. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014;33(19):2142&#x2013;2156. doi: 10.15252/embj.201488104.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201488104</ArticleId><ArticleId IdType="pmc">PMC4282503</ArticleId><ArticleId IdType="pubmed">25107473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605&#x2013;608. doi: 10.1038/33416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/33416</ArticleId><ArticleId IdType="pubmed">9560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, et al. Hereditary early-onset Parkinson&#x2019;s disease caused by mutations in PINK1. Science. 2004;304(5674):1158&#x2013;1160. doi: 10.1126/science.1096284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1096284</ArticleId><ArticleId IdType="pubmed">15087508</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Maestro P, Gargini R, Perry G, Avila J, Garc&#xed;a-Escudero V. PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer&#x2019;s disease. Hum Mol Genet. 2016;25(4):792&#x2013;806. doi: 10.1093/hmg/ddv616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv616</ArticleId><ArticleId IdType="pmc">PMC4743695</ArticleId><ArticleId IdType="pubmed">26721933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X, Sun X, Starovoytov V, Cai Q. Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer&#x2019;s disease patient brains. Hum Mol Genet. 2015;24(10):2938&#x2013;2951. doi: 10.1093/hmg/ddv056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv056</ArticleId><ArticleId IdType="pmc">PMC4406302</ArticleId><ArticleId IdType="pubmed">25678552</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295(5557):1077&#x2013;1079. doi: 10.1126/science.1066901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1066901</ArticleId><ArticleId IdType="pubmed">11834836</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y, Hu X, Sun X. Overexpression of parkin protects retinal ganglion cells in experimental glaucoma article. Cell Death Dis. 2018;9(2):88. doi: 10.1038/s41419-017-0146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0146-9</ArticleId><ArticleId IdType="pmc">PMC5833378</ArticleId><ArticleId IdType="pubmed">29367744</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati V, Dekker MCJ, Vanacore N, Fabbrini G, Squitieri F, Marconi R, et al. Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7. Neurol Sci. 2002;23:59&#x2013;60. doi: 10.1007/s100720200069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s100720200069</ArticleId><ArticleId IdType="pubmed">12548343</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati V, Rizzu P, Van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299(5604):256&#x2013;259. doi: 10.1126/science.1077209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1077209</ArticleId><ArticleId IdType="pubmed">12446870</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44(4):601&#x2013;607. doi: 10.1016/j.neuron.2004.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.11.005</ArticleId><ArticleId IdType="pubmed">15541309</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusdon AM, Zhu J, Van Houten B, Chu CT. ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol Dis. 2012;45(3):962&#x2013;972. doi: 10.1016/j.nbd.2011.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.015</ArticleId><ArticleId IdType="pmc">PMC3291101</ArticleId><ArticleId IdType="pubmed">22198378</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JS, Koentjoro B, Veivers D, Mackay-Sim A, Sue CM. Parkinson&#x2019;s disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction. Hum Mol Genet. 2014;23(11):2802&#x2013;2815. doi: 10.1093/hmg/ddt623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt623</ArticleId><ArticleId IdType="pmc">PMC4014187</ArticleId><ArticleId IdType="pubmed">24399444</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi D, Howard S, Zhou M, Diaz-Perez N, Urban NT, Guerrero-Given D, et al. Identification of a highly neurotoxic &#x3b1;-synuclein species inducing mitochondrial damage and mitophagy in Parkinson&#x2019;s disease. Proc Natl Acad Sci U S A. 2018;115(11):2634&#x2013;2643. doi: 10.1073/pnas.1713849115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1713849115</ArticleId><ArticleId IdType="pmc">PMC5856519</ArticleId><ArticleId IdType="pubmed">29487216</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao LY, Giasson BI, Bonini NM. DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc Natl Acad Sci USA. 2010;107(21):9747&#x2013;9752. doi: 10.1073/pnas.0911175107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911175107</ArticleId><ArticleId IdType="pmc">PMC2906840</ArticleId><ArticleId IdType="pubmed">20457924</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Fonzo A, Roh&#xe9; CF, Ferreira J, Chien HF, Vacca L, Stocchi F, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson&#x2019;s disease. Lancet. 2005;365(9457):412&#x2013;415. doi: 10.1016/S0140-6736(05)17829-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)17829-5</ArticleId><ArticleId IdType="pubmed">15680456</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the &#x3b1;-synuclein gene identified in families with Parkinson&#x2019;s disease. Science. 1997;276(5321):2045&#x2013;2047. doi: 10.1126/science.276.5321.2045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.276.5321.2045</ArticleId><ArticleId IdType="pubmed">9197268</ArticleId></ArticleIdList></Reference><Reference><Citation>International Parkinson Disease Genomics Consortium. Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin U-M, et al. Imputation of sequence variants for identification of genetic risks for Parkinson&#x2019;s disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377(9766):641&#x2013;649. doi: 10.1016/S0140-6736(10)62345-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)62345-8</ArticleId><ArticleId IdType="pmc">PMC3696507</ArticleId><ArticleId IdType="pubmed">21292315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez A, Heimbach A, Gr&#xfc;ndemann J, Stiller B, Hampshire D, Cid LP, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006;38(10):1184&#x2013;1191. doi: 10.1038/ng1884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1884</ArticleId><ArticleId IdType="pubmed">16964263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wauters F, Cornelissen T, Imberechts D, Martin S, Koentjoro B, Sue C, et al. LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10. Autophagy. 2020;16(2):203&#x2013;222. doi: 10.1080/15548627.2019.1603548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1603548</ArticleId><ArticleId IdType="pmc">PMC6984591</ArticleId><ArticleId IdType="pubmed">30945962</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonello F, Hassoun SM, Mouton-Liger F, Shin YS, Muscat A, Tesson C, et al. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson&#x2019;s disease. Hum Mol Genet. 2019;28(10):1645&#x2013;1660. doi: 10.1093/hmg/ddz004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz004</ArticleId><ArticleId IdType="pubmed">30629163</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas KJ, McCoy MK, Blackinton J, Beilina A, van der Brug M, Sandebring A, et al. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet. 2011;20(1):40&#x2013;50. doi: 10.1093/hmg/ddq430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq430</ArticleId><ArticleId IdType="pmc">PMC3000675</ArticleId><ArticleId IdType="pubmed">20940149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;newald A, Arns B, Seibler P, Rakovic A, M&#xfc;nchau A, Ramirez A, et al. ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome. Neurobiol Aging. 2012;33(8):1843.e1-7. doi: 10.1016/j.neurobiolaging.2011.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.12.035</ArticleId><ArticleId IdType="pubmed">22296644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Duan Y, Qin C, Li JC, Duan G, Deng X, et al. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 2018;9(10):953. doi: 10.1038/s41419-018-1022-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1022-y</ArticleId><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo GM, Granatiero V, Kawamata H, Konrad C, Kim M, Arreguin AJ, et al. Parkin is a disease modifier in the mutant SOD 1 mouse model of ALS. EMBO Mol Med. 2018;10(10):e8888. doi: 10.15252/emmm.201808888.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201808888</ArticleId><ArticleId IdType="pmc">PMC6180298</ArticleId><ArticleId IdType="pubmed">30126943</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Li&#xe9;vens JC. PINK1-induced mitophagy promotes neuroprotection in Huntington&#x2019;s disease. Cell Death Dis. 2015;6(1):e1617. doi: 10.1038/cddis.2014.581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.581</ArticleId><ArticleId IdType="pmc">PMC4669776</ArticleId><ArticleId IdType="pubmed">25611391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurubaran IS, Viiri J, Koskela A, Hyttinen JMT, Paterno JJ, Kis G, et al. Mitophagy in the retinal pigment epithelium of dry age-related macular degeneration investigated in the NFE2l2/PGC-1&#x3b1;-/- mouse model. Int J Mol Sci. 2020;21(6):1976. doi: 10.3390/ijms21061976.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21061976</ArticleId><ArticleId IdType="pmc">PMC7139489</ArticleId><ArticleId IdType="pubmed">32183173</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang N, Li L, Chen S, Wang T. PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control. Cell Death Dis. 2016;7(12):1&#x2013;12. doi: 10.1038/cddis.2016.396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2016.396</ArticleId><ArticleId IdType="pmc">PMC5261015</ArticleId><ArticleId IdType="pubmed">27906179</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Ren S, Jiang Y, Wang T. PINK1 and Parkin cooperatively protect neurons against constitutively active TRP channel-induced retinal degeneration in Drosophila. Cell Death Dis. 2016;7(4):e2179&#x2013;e2211. doi: 10.1038/cddis.2016.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2016.82</ArticleId><ArticleId IdType="pmc">PMC4855661</ArticleId><ArticleId IdType="pubmed">27054334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, Iwatsubo T, et al. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an -synuclein rat model of Parkinson&#x2019;s disease. Proc Natl Acad Sci. 2004;101(50):17510&#x2013;17515. doi: 10.1073/pnas.0405313101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0405313101</ArticleId><ArticleId IdType="pmc">PMC536019</ArticleId><ArticleId IdType="pubmed">15576511</ArticleId></ArticleIdList></Reference><Reference><Citation>Vercammen L, Van der Perren A, Vaudano E, Gijsbers R, Debyser Z, Van den Haute C, et al. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson&#x2019;s disease. Mol Ther. 2006;14(5):716&#x2013;723. doi: 10.1016/j.ymthe.2006.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2006.06.009</ArticleId><ArticleId IdType="pubmed">16914382</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterna JC, Leng A, Weber E, Feldon J, B&#xfc;eler H. DJ-1 and parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther. 2007;15(4):698&#x2013;704. doi: 10.1038/sj.mt.6300067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mt.6300067</ArticleId><ArticleId IdType="pubmed">17299411</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredsson FP, Burger C, Sullivan LF, Muzyczka N, Lewin AS, Mandel RJ. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson&#x2019;s disease. Exp Neurol. 2007;207(2):289&#x2013;301. doi: 10.1016/j.expneurol.2007.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2007.06.019</ArticleId><ArticleId IdType="pubmed">17678648</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein RL, Dayton RD, Henderson KM, Petrucelli L. Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model. Neurosci Lett. 2006;401(1&#x2013;2):130&#x2013;135. doi: 10.1016/j.neulet.2006.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2006.03.001</ArticleId><ArticleId IdType="pmc">PMC2975302</ArticleId><ArticleId IdType="pubmed">16554120</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Traini R, Killinger B, Schneider B, Moszczynska A. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity. Exp Neurol. 2013;247:359&#x2013;372. doi: 10.1016/j.expneurol.2013.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.01.001</ArticleId><ArticleId IdType="pmc">PMC4321803</ArticleId><ArticleId IdType="pubmed">23313192</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rompuy AS, Lobbestael E, Van der Perren A, Van den Haute C, Baekelandt V. Long-term overexpression of human wild-type and T240R Mutant Parkin in rat substantia nigra induces progressive dopaminergic neurodegeneration. J Neuropathol Exp Neurol. 2014;73(2):159&#x2013;174. doi: 10.1097/NEN.0000000000000039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000039</ArticleId><ArticleId IdType="pubmed">24423640</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda T, Miyachi S, Kitagawa R, Wada K, Nihira T, Ren YR, et al. Neuronal specificity of &#x3b1;-synuclein toxicity and effect of Parkin co-expression in primates. Neuroscience. 2007;144(2):743&#x2013;753. doi: 10.1016/j.neuroscience.2006.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2006.09.052</ArticleId><ArticleId IdType="pubmed">17101231</ArticleId></ArticleIdList></Reference><Reference><Citation>Du F, Yu Q, Yan S, Hu G, Lue LF, Walker DG, et al. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer&#x2019;s disease. Brain. 2017;140(12):3233&#x2013;3251. doi: 10.1093/brain/awx258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx258</ArticleId><ArticleId IdType="pmc">PMC5841141</ArticleId><ArticleId IdType="pubmed">29077793</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimura H, Hattori N, Kubo SI, Mizuno Y, Asakawa S, Minoshima S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000;25(3):302&#x2013;305. doi: 10.1038/77060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/77060</ArticleId><ArticleId IdType="pubmed">10888878</ArticleId></ArticleIdList></Reference><Reference><Citation>Spratt DE, Walden H, Shaw GS. RBR E3 ubiquitin ligases: new structures, new insights, new questions. Biochem J. 2014;458(3):421&#x2013;437. doi: 10.1042/BJ20140006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20140006</ArticleId><ArticleId IdType="pmc">PMC3940038</ArticleId><ArticleId IdType="pubmed">24576094</ArticleId></ArticleIdList></Reference><Reference><Citation>Morett E, Bork P. A novel transactivation domain in parkin. Trends Biochem Sci. 1999;24(6):229&#x2013;231. doi: 10.1016/S0968-0004(99)01381-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0968-0004(99)01381-X</ArticleId><ArticleId IdType="pubmed">10366851</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley BE, Lougheed JC, Callaway K, Velasquez M, Brecht E, Nguyen L, et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun. 2013;4:1982. doi: 10.1038/ncomms2982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2982</ArticleId><ArticleId IdType="pmc">PMC3709503</ArticleId><ArticleId IdType="pubmed">23770887</ArticleId></ArticleIdList></Reference><Reference><Citation>Trempe JF, Sauv&#xe9; V, Grenier K, Seirafi M, Tang MY, Me&#x144;ade M, et al. Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science. 2013;340(6139):1451&#x2013;1455. doi: 10.1126/science.1237908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1237908</ArticleId><ArticleId IdType="pubmed">23661642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hristova VA, Beasley SA, Rylett RJ, Shaw GS. Identification of a novel Zn2+ -binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J Biol Chem. 2009;284(22):14978&#x2013;14986. doi: 10.1074/jbc.M808700200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M808700200</ArticleId><ArticleId IdType="pmc">PMC2685680</ArticleId><ArticleId IdType="pubmed">19339245</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol. 2010;189(2):211&#x2013;221. doi: 10.1083/jcb.200910140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200910140</ArticleId><ArticleId IdType="pmc">PMC2856912</ArticleId><ArticleId IdType="pubmed">20404107</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8(1):e1000298. doi: 10.1371/journal.pbio.1000298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000298</ArticleId><ArticleId IdType="pmc">PMC2811155</ArticleId><ArticleId IdType="pubmed">20126261</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183(5):795&#x2013;803. doi: 10.1083/jcb.200809125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200809125</ArticleId><ArticleId IdType="pmc">PMC2592826</ArticleId><ArticleId IdType="pubmed">19029340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309&#x2013;314. doi: 10.1038/nature14893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14893</ArticleId><ArticleId IdType="pmc">PMC5018156</ArticleId><ArticleId IdType="pubmed">26266977</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, et al. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 2012;13(4):378&#x2013;385. doi: 10.1038/embor.2012.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2012.14</ArticleId><ArticleId IdType="pmc">PMC3321149</ArticleId><ArticleId IdType="pubmed">22354088</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol. 2010;191(5):933&#x2013;942. doi: 10.1083/jcb.201008084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201008084</ArticleId><ArticleId IdType="pmc">PMC2995166</ArticleId><ArticleId IdType="pubmed">21115803</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Guardia-Laguarta C, Yin J, Erdjument-Bromage H, Martin B, James M, et al. The Ubiquitination of PINK1 Is Restricted to Its Mature 52-kDa Form. Cell Rep. 2017;20(1):30&#x2013;39. doi: 10.1016/j.celrep.2017.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.06.022</ArticleId><ArticleId IdType="pmc">PMC5745057</ArticleId><ArticleId IdType="pubmed">28683321</ArticleId></ArticleIdList></Reference><Reference><Citation>Deas E, Plun-Favreau H, Gandhi S, Desmond H, Kjaer S, Loh SHY, et al. PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet. 2011;20(5):867&#x2013;879. doi: 10.1093/hmg/ddq526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq526</ArticleId><ArticleId IdType="pmc">PMC3033179</ArticleId><ArticleId IdType="pubmed">21138942</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano K, Youle RJ. PINK1 is degraded through the N-end rule pathway. Autophagy. 2013;9(11):1758&#x2013;1769. doi: 10.4161/auto.24633.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.24633</ArticleId><ArticleId IdType="pmc">PMC4028335</ArticleId><ArticleId IdType="pubmed">24121706</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine S, Wang C, Sideris DP, Bunker E, Zhang Z, Youle RJ. Reciprocal roles of Tom7 and OMA1 during mitochondrial import and activation of PINK1. Mol Cell. 2019;73(5):1028-1043.e5. doi: 10.1016/j.molcel.2019.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.01.002</ArticleId><ArticleId IdType="pubmed">30733118</ArticleId></ArticleIdList></Reference><Reference><Citation>Guardia-Laguarta C, Liu Y, Lauritzen KH, Erdjument-Bromage H, Martin B, Swayne TC, et al. PINK1 content in mitochondria is regulated by ER-associated degradation. J Neurosci. 2019;39(36):7074&#x2013;7085. doi: 10.1523/JNEUROSCI.1691-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1691-18.2019</ArticleId><ArticleId IdType="pmc">PMC6733537</ArticleId><ArticleId IdType="pubmed">31300519</ArticleId></ArticleIdList></Reference><Reference><Citation>Okatsu K, Uno M, Koyano F, Go E, Kimura M, Oka T, et al. A dimeric pink1-containing complex on depolarized mitochondria stimulates parkin recruitment. J Biol Chem. 2013;288(51):36372&#x2013;36384. doi: 10.1074/jbc.M113.509653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.509653</ArticleId><ArticleId IdType="pmc">PMC3868751</ArticleId><ArticleId IdType="pubmed">24189060</ArticleId></ArticleIdList></Reference><Reference><Citation>Okatsu K, Oka T, Iguchi M, Imamura K, Kosako H, Tani N, et al. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat Commun. 2012;3:1010&#x2013;1016. doi: 10.1038/ncomms2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2016</ArticleId><ArticleId IdType="pmc">PMC3432468</ArticleId><ArticleId IdType="pubmed">22910362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W, Karuppagounder SS, Springer DA, Allen MD, Zheng L, Chao B, et al. Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson&#x2019;s-like movement disorder. Nat Commun. 2014;5(7):4930. doi: 10.1038/ncomms5930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5930</ArticleId><ArticleId IdType="pmc">PMC4457367</ArticleId><ArticleId IdType="pubmed">25222142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wauer T, Komander D. Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J. 2013;32(15):2099&#x2013;2112. doi: 10.1038/emboj.2013.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.125</ArticleId><ArticleId IdType="pmc">PMC3730226</ArticleId><ArticleId IdType="pubmed">23727886</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ, Shaw GS, et al. Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 2011;30(14):2853&#x2013;2867. doi: 10.1038/emboj.2011.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.204</ArticleId><ArticleId IdType="pmc">PMC3160258</ArticleId><ArticleId IdType="pubmed">21694720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Aguirre JD, Condos TE, Martinez-Torres RJ, Chaugule VK, Toth R, et al. Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis. EMBO J. 2015;34(20):2506&#x2013;2521. doi: 10.15252/embj.201592337.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592337</ArticleId><ArticleId IdType="pmc">PMC4609183</ArticleId><ArticleId IdType="pubmed">26254304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauv&#xe9; V, Lilov A, Seirafi M, Vranas M, Rasool S, Kozlov G, et al. A Ubl/ubiquitin switch in the activation of Parkin. EMBO J. 2015;34(20):2492&#x2013;2505. doi: 10.15252/embj.201592237.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592237</ArticleId><ArticleId IdType="pmc">PMC4609182</ArticleId><ArticleId IdType="pubmed">26254305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Chaugule VK, Condos TEC, Barber KR, Johnson C, Toth R, et al. Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity. Nat Struct Mol Biol. 2017;24(5):475&#x2013;483. doi: 10.1038/nsmb.3400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3400</ArticleId><ArticleId IdType="pmc">PMC5420311</ArticleId><ArticleId IdType="pubmed">28414322</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel DM, Lissounov A, Brzovic PS, Klevit RE. UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature. 2011;474(7349):105&#x2013;108. doi: 10.1038/nature09966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09966</ArticleId><ArticleId IdType="pmc">PMC3444301</ArticleId><ArticleId IdType="pubmed">21532592</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006;441(7097):1157&#x2013;1161. doi: 10.1038/nature04788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04788</ArticleId><ArticleId IdType="pubmed">16672980</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006;441(7097):1162&#x2013;1166. doi: 10.1038/nature04779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04779</ArticleId><ArticleId IdType="pubmed">16672981</ArticleId></ArticleIdList></Reference><Reference><Citation>Pao K, Stanley M, Han C, Lai Y, Murphy P, Wood NT, et al. Probes of ubiquitin E3 ligases distinguish different stages of Parkin activation. Nat Chem Biol. 2016;12(5):324&#x2013;331. doi: 10.1038/nchembio.2045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2045</ArticleId><ArticleId IdType="pmc">PMC4909137</ArticleId><ArticleId IdType="pubmed">26928937</ArticleId></ArticleIdList></Reference><Reference><Citation>Wauer T, Simicek M, Schubert A, Komander D. Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature. 2015;524(7565):370&#x2013;374. doi: 10.1038/nature14879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14879</ArticleId><ArticleId IdType="pmc">PMC4984986</ArticleId><ArticleId IdType="pubmed">26161729</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 2014;510(7503):162&#x2013;166. doi: 10.1038/nature13392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13392</ArticleId><ArticleId IdType="pubmed">24784582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, et al. Accelerated publication: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem J. 2014;460(1):127&#x2013;139. doi: 10.1042/BJ20140334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20140334</ArticleId><ArticleId IdType="pmc">PMC4000136</ArticleId><ArticleId IdType="pubmed">24660806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, et al. PINK1 phosphorylates ubiquitin to activate parkin E3 ubiquitin ligase activity. J Cell Biol. 2014;205(2):143&#x2013;153. doi: 10.1083/jcb.201402104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201402104</ArticleId><ArticleId IdType="pmc">PMC4003245</ArticleId><ArticleId IdType="pubmed">24751536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazlauskaite A, Mart&#xed;nez-Torres RJ, Wilkie S, Kumar A, Peltier J, Gonzalez A, et al. Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK 1-dependent phosphorylation and activation. EMBO Rep. 2015;16(8):939&#x2013;954. doi: 10.15252/embr.201540352.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201540352</ArticleId><ArticleId IdType="pmc">PMC4552487</ArticleId><ArticleId IdType="pubmed">26116755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordureau A, Sarraf SA, Duda DM, Heo JM, Jedrychowski MP, Sviderskiy VO, et al. Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol Cell. 2014;56(3):360&#x2013;375. doi: 10.1016/j.molcel.2014.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.09.007</ArticleId><ArticleId IdType="pmc">PMC4254048</ArticleId><ArticleId IdType="pubmed">25284222</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguirre JD, Dunkerley KM, Mercier P, Shaw GS. Structure of phosphorylated UBL domain and insights into PINK1-orchestrated parkin activation. Proc Natl Acad Sci USA. 2017;114(2):298&#x2013;303. doi: 10.1073/pnas.1613040114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613040114</ArticleId><ArticleId IdType="pmc">PMC5240717</ArticleId><ArticleId IdType="pubmed">28007983</ArticleId></ArticleIdList></Reference><Reference><Citation>Caulfield TR, Fiesel FC, Moussaud-Lamodi&#xe8;re EL, Dourado DFAR, Flores SC, Springer W. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase parkin. PLoS Comput Biol. 2014;10(11):e1003935. doi: 10.1371/journal.pcbi.1003935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003935</ArticleId><ArticleId IdType="pmc">PMC4222639</ArticleId><ArticleId IdType="pubmed">25375667</ArticleId></ArticleIdList></Reference><Reference><Citation>Spratt DE, Julio Martinez-Torres R, Noh YJ, Mercier P, Manczyk N, Barber KR, et al. A molecular explanation for the recessive nature of parkin-linked Parkinson&#x2019;s disease. Nat Commun. 2013;4:1&#x2013;12. doi: 10.1038/ncomms2983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2983</ArticleId><ArticleId IdType="pmc">PMC3709501</ArticleId><ArticleId IdType="pubmed">23770917</ArticleId></ArticleIdList></Reference><Reference><Citation>Safadi SS, Barber KR, Shaw GS. Impact of autosomal recessive juvenile Parkinson&#x2019;s disease mutations on the structure and interactions of the parkin ubiquitin-like domain. Biochemistry. 2011;50(13):2603&#x2013;2610. doi: 10.1021/bi200065g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi200065g</ArticleId><ArticleId IdType="pmc">PMC3065874</ArticleId><ArticleId IdType="pubmed">21348451</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampe C, Ardila-Osorio H, Fournier M, Brice A, Corti O. Biochemical analysis of Parkinson&#x2019;s disease-causing variants of Parkin, an E3 ubiquitin&#x2014;protein ligase with monoubiquitylation capacity. Hum Mol Genet. 2006;15(13):2059&#x2013;2075. doi: 10.1093/hmg/ddl131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddl131</ArticleId><ArticleId IdType="pubmed">16714300</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo J-M, Ordureau A, Paulo JA, Rinehart J, Harper JW. The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell. 2015;60(1):7&#x2013;20. doi: 10.1016/j.molcel.2015.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.08.016</ArticleId><ArticleId IdType="pmc">PMC4592482</ArticleId><ArticleId IdType="pubmed">26365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraf SA, Sideris DP, Giagtzoglou N, Ni L, Kankel MW, Sen A, et al. PINK1/parkin influences cell cycle by sequestering TBK1 at damaged mitochondria, inhibiting mitosis. Cell Rep. 2019;29(1):225-235.e5. doi: 10.1016/j.celrep.2019.08.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.08.085</ArticleId><ArticleId IdType="pmc">PMC6880866</ArticleId><ArticleId IdType="pubmed">31577952</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas JNS, Wang C, Bunker E, Hao L, Maric D, Schiavo G, et al. Spatiotemporal control of ULK1 Activation by NDP52 and TBK1 during selective autophagy. Mol Cell. 2019;74(2):347-362.e6. doi: 10.1016/j.molcel.2019.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.02.010</ArticleId><ArticleId IdType="pmc">PMC6642318</ArticleId><ArticleId IdType="pubmed">30853401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozawa T, Sano S, Minowa-Nozawa A, Toh H, Nakajima S, Murase K, et al. TBC1D9 regulates TBK1 activation through Ca2+ signaling in selective autophagy. Nat Commun. 2020;11(1):1&#x2013;16. doi: 10.1038/s41467-020-14533-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14533-4</ArticleId><ArticleId IdType="pmc">PMC7005872</ArticleId><ArticleId IdType="pubmed">32034138</ArticleId></ArticleIdList></Reference><Reference><Citation>Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: what is it and where are we? J Clin Invest. 2003;111(1):3&#x2013;10. doi: 10.1172/JCI200317522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200317522</ArticleId><ArticleId IdType="pmc">PMC151843</ArticleId><ArticleId IdType="pubmed">12511579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornelissen T, Vilain S, Vints K, Gounko N, Verstreken P, Vandenberghe W. Deficiency of parkin and PINK1 impairs age-dependent mitophagy in drosophila. Elife. 2018;7:1&#x2013;14. doi: 10.7554/eLife.35878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.35878</ArticleId><ArticleId IdType="pmc">PMC6008047</ArticleId><ArticleId IdType="pubmed">29809156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel FC, Ando M, Hudec R, Hill AR, Castanedes-Casey M, Caulfield TR, et al. (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. EMBO Rep. 2015;16(9):1114&#x2013;1130. doi: 10.15252/embr.201540514.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201540514</ArticleId><ArticleId IdType="pmc">PMC4576981</ArticleId><ArticleId IdType="pubmed">26162776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickrell AM, Huang C-HH, Kennedy SR, Ordureau A, Sideris DP, Hoekstra JG, et al. Endogenous parkin preserves dopaminergic substantia Nigral neurons following mitochondrial DNA mutagenic stress. Neuron. 2015;87(2):371&#x2013;382. doi: 10.1016/j.neuron.2015.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.06.034</ArticleId><ArticleId IdType="pmc">PMC4803114</ArticleId><ArticleId IdType="pubmed">26182419</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo D, Kang C, Gomez-Cabrera MC, Vina J, Ji LL. Intensified mitophagy in skeletal muscle with aging is downregulated by PGC-1alpha overexpression in vivo. Free Radic Biol Med. 2019;130:361&#x2013;368. doi: 10.1016/j.freeradbiomed.2018.10.456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.10.456</ArticleId><ArticleId IdType="pubmed">30395971</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X, Fiesel FC, Truban D, Castanedes Casey M, Lin WL, Soto AI, et al. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease. Autophagy. 2018;14(8):1404&#x2013;1418. doi: 10.1080/15548627.2018.1461294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1461294</ArticleId><ArticleId IdType="pmc">PMC6372017</ArticleId><ArticleId IdType="pubmed">29947276</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman SB, Pineda FJ, Hardwick JM. Mitochondrial fission and fusion dynamics: the long and short of it. Cell Death Differ. 2008;15(7):1147&#x2013;1152. doi: 10.1038/cdd.2008.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2008.57</ArticleId><ArticleId IdType="pmc">PMC2614113</ArticleId><ArticleId IdType="pubmed">18437161</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, Sun Y, Guo S, Lu B. The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Hum Mol Genet. 2011;20(16):3227&#x2013;3240. doi: 10.1093/hmg/ddr235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr235</ArticleId><ArticleId IdType="pmc">PMC3140825</ArticleId><ArticleId IdType="pubmed">21613270</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer&#x2019;s disease in a community population of older persons: higher than previously reported. JAMA, J Am Med Assoc. 1989;262(18):2551&#x2013;2556. doi: 10.1001/jama.1989.03430180093036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1989.03430180093036</ArticleId><ArticleId IdType="pubmed">2810583</ArticleId></ArticleIdList></Reference><Reference><Citation>Deture MA, Dickson DW. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol Neurodegener. 2019;14(1):1&#x2013;18. doi: 10.1186/s13024-019-0333-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer&#x2019;s disease pathophysiology. Biochim Biophys Acta&#x2014;Mol Basis Dis. 2010;1802(1):2&#x2013;10. doi: 10.1016/j.bbadis.2009.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.10.006</ArticleId><ArticleId IdType="pubmed">19853658</ArticleId></ArticleIdList></Reference><Reference><Citation>Goiran T, Duplan E, Chami M, Bourgeois A, El Manaa W, Rouland L, et al. &#x3b2;-amyloid precursor protein intracellular domain controls mitochondrial function by modulating phosphatase and tensin homolog-induced kinase 1 transcription in cells and in alzheimer mice models. Biol Psychiatry. 2018;83(5):416&#x2013;427. doi: 10.1016/j.biopsych.2017.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2017.04.011</ArticleId><ArticleId IdType="pubmed">28587718</ArticleId></ArticleIdList></Reference><Reference><Citation>Checler F, Goiran T, Alves da Costa C. Presenilins at the crossroad of a functional interplay between PARK2/PARKIN and PINK1 to control mitophagy: implication for neurodegenerative diseases. Autophagy. 2017;13(11):2004&#x2013;2005. doi: 10.1080/15548627.2017.1363950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1363950</ArticleId><ArticleId IdType="pmc">PMC5788489</ArticleId><ArticleId IdType="pubmed">28914586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnet AM, Jutras MF, Czernecki V, Corvol JC, Vidailhet M. Nonmotor symptoms in Parkinsons disease in 2012: relevant clinical aspects. Parkinsons Dis. 2012;2012:198316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3410355</ArticleId><ArticleId IdType="pubmed">22888466</ArticleId></ArticleIdList></Reference><Reference><Citation>Savitt JM, Dawson VL, Dawson TM. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest. 2006;116(7):1744&#x2013;1754. doi: 10.1172/JCI29178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29178</ArticleId><ArticleId IdType="pmc">PMC1483178</ArticleId><ArticleId IdType="pubmed">16823471</ArticleId></ArticleIdList></Reference><Reference><Citation>Julienne H, Buhl E, Leslie DS, Hodge JJL. Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson&#x2019;s disease phenotypes. Neurobiol Dis. 2017;104:15&#x2013;23. doi: 10.1016/j.nbd.2017.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.04.014</ArticleId><ArticleId IdType="pmc">PMC5469398</ArticleId><ArticleId IdType="pubmed">28435104</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9(1):13&#x2013;24. doi: 10.1038/nrneurol.2012.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.242</ArticleId><ArticleId IdType="pubmed">23183883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee VMY, Trojanowski JQ. Mechanisms of Parkinson&#x2019;s disease linked to pathological &#x3b1;-synuclein: new targets for drug discovery. Neuron. 2006;52(1):33&#x2013;38. doi: 10.1016/j.neuron.2006.09.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.026</ArticleId><ArticleId IdType="pubmed">17015225</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh CK, Sultan A, Platzer J, Dolatabadi N, Soldner F, McClatchy DB, et al. S-nitrosylation of PINK1 attenuates PINK1/parkin-dependent mitophagy in hiPSC-based Parkinson&#x2019;s disease models. Cell Rep. 2017;21(8):2171&#x2013;2182. doi: 10.1016/j.celrep.2017.10.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.10.068</ArticleId><ArticleId IdType="pmc">PMC5705204</ArticleId><ArticleId IdType="pubmed">29166608</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, et al. Nitrosative stress linked to sporadic Parkinson&#x2019;s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA. 2004;101(29):10810&#x2013;10814. doi: 10.1073/pnas.0404161101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0404161101</ArticleId><ArticleId IdType="pmc">PMC490016</ArticleId><ArticleId IdType="pubmed">15252205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizza S, Cardaci S, Montagna C, Di Giacomo G, De Zio D, Bordi M, et al. S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy. Proc Natl Acad Sci USA. 2018;115(15):3388&#x2013;3397. doi: 10.1073/pnas.1722452115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1722452115</ArticleId><ArticleId IdType="pmc">PMC5899480</ArticleId><ArticleId IdType="pubmed">29581312</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 2007;69(12):1270&#x2013;1277. doi: 10.1212/01.wnl.0000276989.17578.02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000276989.17578.02</ArticleId><ArticleId IdType="pmc">PMC3624967</ArticleId><ArticleId IdType="pubmed">17875915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesage S, Bras J, Cormier-Dequaire F, Condroyer C, Nicolas A, Darwent L, et al. Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease. Neurol Genet. 2015;1(1):e9. doi: 10.1212/NXG.0000000000000009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000009</ArticleId><ArticleId IdType="pmc">PMC4821081</ArticleId><ArticleId IdType="pubmed">27066548</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu G, Ping Z, Sun Y, Fang X, Wei H, et al. PINK1 and its familial Parkinson&#x2019;s disease-associated mutation regulate brain vascular endothelial inflammation. J Mol Neurosci. 2014;53(1):109&#x2013;116. doi: 10.1007/s12031-013-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-013-0185-3</ArticleId><ArticleId IdType="pubmed">24385196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockhart PJ, Lincoln S, Hulihan M, Kachergus J, Wilkes K, Bisceglio G, et al. DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function. J Med Genet. 2004;41(3):1&#x2013;6. doi: 10.1136/jmg.2003.011106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2003.011106</ArticleId><ArticleId IdType="pmc">PMC1735689</ArticleId><ArticleId IdType="pubmed">14985393</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, et al. Parkin-deficient Mice Exhibit Nigrostriatal Deficits but not Loss of Dopaminergic Neurons. J Biol Chem. 2003;278(44):43628&#x2013;43635. doi: 10.1074/jbc.M308947200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M308947200</ArticleId><ArticleId IdType="pubmed">12930822</ArticleId></ArticleIdList></Reference><Reference><Citation>Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, Becker D, et al. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS ONE. 2009;4(6):e5777. doi: 10.1371/journal.pone.0005777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005777</ArticleId><ArticleId IdType="pmc">PMC2686165</ArticleId><ArticleId IdType="pubmed">19492057</ArticleId></ArticleIdList></Reference><Reference><Citation>Itier JM, Ib&#xe1;&#xf1;ez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA, et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet. 2003;12(18):2277&#x2013;2291. doi: 10.1093/hmg/ddg239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg239</ArticleId><ArticleId IdType="pubmed">12915482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G, et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci. 2007;104(27):11441&#x2013;11446. doi: 10.1073/pnas.0702717104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0702717104</ArticleId><ArticleId IdType="pmc">PMC1890561</ArticleId><ArticleId IdType="pubmed">17563363</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez FA, Palmiter RD. Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci. 2005;102(6):2174&#x2013;2179. doi: 10.1073/pnas.0409598102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409598102</ArticleId><ArticleId IdType="pmc">PMC548311</ArticleId><ArticleId IdType="pubmed">15684050</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave KD, De Silva S, Sheth NP, Ramboz S, Beck MJ, Quang C, et al. Phenotypic characterization of recessive gene knockout rat models of Parkinson&#x2019;s disease. Neurobiol Dis. 2014;70:190&#x2013;203. doi: 10.1016/j.nbd.2014.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.06.009</ArticleId><ArticleId IdType="pubmed">24969022</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson SEM, Aumann TD, Taylor JM, Riseley JR, Li R, Mann JR, et al. Generation and characterisation of a parkin-Pacrg knockout mouse line and a Pacrg knockout mouse line. Sci Rep. 2018;8(1):1&#x2013;11. doi: 10.1038/s41598-018-25766-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25766-1</ArticleId><ArticleId IdType="pmc">PMC5951884</ArticleId><ArticleId IdType="pubmed">29760428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Kang X, Zhou L, Chai Z, Wu Q, Huang R, et al. Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson&#x2019;s disease-like pathology. Nat Commun. 2018;9(1):1&#x2013;14. doi: 10.1038/s41467-017-02088-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02088-w</ArticleId><ArticleId IdType="pmc">PMC5758517</ArticleId><ArticleId IdType="pubmed">29311685</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, et al. PARIS (ZNF746) repression of PGC-1&#x3b1; contributes to neurodegeneration in parkinson&#x2019;s disease. Cell. 2011;144(5):689&#x2013;702. doi: 10.1016/j.cell.2011.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.02.010</ArticleId><ArticleId IdType="pmc">PMC3063894</ArticleId><ArticleId IdType="pubmed">21376232</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmachari S, Lee S, Kim S, Yuan C, Karuppagounder SS, Ge P, et al. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson&#x2019;s disease. Brain. 2019;142(8):2380&#x2013;2401. doi: 10.1093/brain/awz172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz172</ArticleId><ArticleId IdType="pmc">PMC6658849</ArticleId><ArticleId IdType="pubmed">31237944</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Karuppagounder SS, Shin JH, Lee Y-I, Ko HS, Swing D, et al. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci. 2013;16(10):1392&#x2013;1400. doi: 10.1038/nn.3500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3500</ArticleId><ArticleId IdType="pmc">PMC3785563</ArticleId><ArticleId IdType="pubmed">23974709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko HS, Von Coelln R, Sriram SR, Kim SW, Chung KKK, Pletnikova O, et al. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J Neurosci. 2005;25(35):7968&#x2013;7978. doi: 10.1523/JNEUROSCI.2172-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2172-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725452</ArticleId><ArticleId IdType="pubmed">16135753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, et al. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin&#x2019;s ubiquitination and protective function. Proc Natl Acad Sci USA. 2010;107(38):16691&#x2013;16696. doi: 10.1073/pnas.1006083107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006083107</ArticleId><ArticleId IdType="pmc">PMC2944759</ArticleId><ArticleId IdType="pubmed">20823226</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa CA, Duplan E, Rouland L, Checler F. The transcription factor function of Parkin: breaking the dogma. Front Neurosci. 2018;12:965. doi: 10.3389/fnins.2018.00965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00965</ArticleId><ArticleId IdType="pmc">PMC6341214</ArticleId><ArticleId IdType="pubmed">30697141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao SY. DNA damage induces nuclear translocation of parkin. J Biomed Sci. 2009;16(1):1&#x2013;9. doi: 10.1186/1423-0127-16-67.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-16-67</ArticleId><ArticleId IdType="pmc">PMC2720942</ArticleId><ArticleId IdType="pubmed">19615059</ArticleId></ArticleIdList></Reference><Reference><Citation>Shires SE, Quiles JM, Najor RH, Leon LJ, Cortez MQ, Lampert MA, et al. Nuclear Parkin activates the ERR&#x3b1; transcriptional program and drives widespread changes in gene expression following hypoxia. Sci Rep. 2020;10(1):1&#x2013;15. doi: 10.1038/s41598-020-65438-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-65438-7</ArticleId><ArticleId IdType="pmc">PMC7244578</ArticleId><ArticleId IdType="pubmed">32444656</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives-Bauza C, Zhou C, Huang Y, Cui M, De Vries RLA, Kim J, et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA. 2010;107(1):378&#x2013;383. doi: 10.1073/pnas.0911187107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911187107</ArticleId><ArticleId IdType="pmc">PMC2806779</ArticleId><ArticleId IdType="pubmed">19966284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhi L, Qin Q, Muqeem T, Seifert EL, Liu W, Zheng S, et al. Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction. Neurobiol Aging. 2019;75:1&#x2013;10. doi: 10.1016/j.neurobiolaging.2018.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.10.025</ArticleId><ArticleId IdType="pmc">PMC6778692</ArticleId><ArticleId IdType="pubmed">30504091</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez CJ, B&#xe1;ez-Becerra C, Contreras-Z&#xe1;rate MJ, Arboleda H, Arboleda G. PINK1 silencing modifies dendritic spine dynamics of mouse hippocampal neurons. J Mol Neurosci. 2019;69(4):570&#x2013;579. doi: 10.1007/s12031-019-01385-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-019-01385-x</ArticleId><ArticleId IdType="pubmed">31486971</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliams TG, Prescott AR, Montava-Garriga L, Ball G, Singh F, Barini E, et al. Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand. Cell Metab. 2018;27(2):439-449.e5. doi: 10.1016/j.cmet.2017.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.12.008</ArticleId><ArticleId IdType="pmc">PMC5807059</ArticleId><ArticleId IdType="pubmed">29337137</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Liu Y, Tu Z, Xiao C, Yan S, Ma X, et al. CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys. Cell Res. 2019;29(4):334&#x2013;336. doi: 10.1038/s41422-019-0142-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0142-y</ArticleId><ArticleId IdType="pmc">PMC6461954</ArticleId><ArticleId IdType="pubmed">30770867</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Li S, Li XJ. A CRISPR monkey model unravels a unique function of PINK1 in primate brains. Mol Neurodegener. 2019;14(1):1&#x2013;4. doi: 10.1186/s13024-019-0321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0321-9</ArticleId><ArticleId IdType="pmc">PMC6498691</ArticleId><ArticleId IdType="pubmed">31046796</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheoud D, Cannon T, Voisin A, Penttinen A-M, Ramet L, Fahmy AM, et al. Intestinal infection triggers Parkinson&#x2019;s disease-like symptoms in Pink1&#x2009;&#x2212;/&#x2212;&#x2009;mice. Nature. 2019;571(7766):565&#x2013;569. doi: 10.1038/s41586-019-1405-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1405-y</ArticleId><ArticleId IdType="pubmed">31316206</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with Parkinson&#x2019;s disease recognize &#x3b1;-synuclein peptides. Nature. 2017;546(7660):656&#x2013;661. doi: 10.1038/nature22815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22815</ArticleId><ArticleId IdType="pmc">PMC5626019</ArticleId><ArticleId IdType="pubmed">28636593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer A, Maxreiter F, Krach F, Fadler T, Grosch J, Maroni M, et al. Th17 lymphocytes induce neuronal cell death in a Human iPSC-based model of Parkinson&#x2019;s disease. Cell Stem Cell. 2018;23(1):123-131.e6. doi: 10.1016/j.stem.2018.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2018.06.015</ArticleId><ArticleId IdType="pubmed">29979986</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Li G, Xu J, Gao S, Chen X. The challenge of the pathogenesis of Parkinson&#x2019;s disease: is autoimmunity the culprit? Front Immunol. 2018;9:2047. doi: 10.3389/fimmu.2018.02047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02047</ArticleId><ArticleId IdType="pmc">PMC6170625</ArticleId><ArticleId IdType="pubmed">30319601</ArticleId></ArticleIdList></Reference><Reference><Citation>Garretti F, Agalliu D, Arlehamn CSL, Sette A, Sulzer D. Autoimmmunity in parkinson&#x2019;s disease: the role of &#x3b1;:-synuclein-specific T cells. Front Immunol. 2019;10:1&#x2013;12. doi: 10.3389/fimmu.2019.00303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00303</ArticleId><ArticleId IdType="pmc">PMC6397885</ArticleId><ArticleId IdType="pubmed">30858851</ArticleId></ArticleIdList></Reference><Reference><Citation>Amor S, Peferoen LAN, Vogel DYS, Breur M, van der Valk P, Baker D, et al. Inflammation in neurodegenerative diseases - an update. Immunology. 2014;142(2):151&#x2013;166. doi: 10.1111/imm.12233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12233</ArticleId><ArticleId IdType="pmc">PMC4008224</ArticleId><ArticleId IdType="pubmed">24329535</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, Chemali M, et al. Parkinson&#x2019;s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell. 2016;166(2):314&#x2013;327. doi: 10.1016/j.cell.2016.05.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.039</ArticleId><ArticleId IdType="pubmed">27345367</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans CS, Holzbaur ELF. Autophagy and mitophagy in ALS. Neurobiol Dis. 2019;122(215):35&#x2013;40. doi: 10.1016/j.nbd.2018.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.005</ArticleId><ArticleId IdType="pmc">PMC6366665</ArticleId><ArticleId IdType="pubmed">29981842</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(11):1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S, Sipos J, Thau-Habermann N, K&#xf6;rner S, Rath KJ, Dengler R, et al. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1G93A ALS mouse model. J Neuropathol Exp Neurol. 2013;72(11):1052&#x2013;1061. doi: 10.1097/NEN.0000000000000004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000004</ArticleId><ArticleId IdType="pubmed">24128678</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci. 2012;15(11):1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos RAC. Huntington&#x2019;s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40. doi: 10.1186/1750-1172-5-40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-5-40</ArticleId><ArticleId IdType="pmc">PMC3022767</ArticleId><ArticleId IdType="pubmed">21171977</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte J, Littleton JT. The biological function of the Huntingtin protein and its relevance to Huntington&#x2019;s Disease pathology. Curr Trends Neurol. 2011;5:65&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3237673</ArticleId><ArticleId IdType="pubmed">22180703</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco-Iborra S, Plaza-Zabala A, Montpeyo M, Sebastian D, Vila M, Martinez-Vicente M (2020) Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease. Autophagy 1&#x2013;18. https://pubmed.ncbi.nlm.nih.gov/32093570/</Citation><ArticleIdList><ArticleId IdType="pubmed">32093570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, et al. Mitochondrial loss, dysfunction and altered dynamics in Huntington&#x2019;s disease. Hum Mol Genet. 2010;19(20):3919&#x2013;3935. doi: 10.1093/hmg/ddq306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq306</ArticleId><ArticleId IdType="pmc">PMC2947400</ArticleId><ArticleId IdType="pubmed">20660112</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, et al. Mutant Huntingtin&#x2019;s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington&#x2019;s disease. Hum Mol Genet. 2012;21(2):406&#x2013;420. doi: 10.1093/hmg/ddr475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr475</ArticleId><ArticleId IdType="pmc">PMC3276281</ArticleId><ArticleId IdType="pubmed">21997870</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med. 2011;17(3):377&#x2013;382. doi: 10.1038/nm.2313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2313</ArticleId><ArticleId IdType="pmc">PMC3051025</ArticleId><ArticleId IdType="pubmed">21336284</ArticleId></ArticleIdList></Reference><Reference><Citation>Squitieri F, Cannella M, Sgarbi G, Maglione V, Falleni A, Lenzi P, et al. Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev. 2006;127(2):217&#x2013;220. doi: 10.1016/j.mad.2005.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2005.09.010</ArticleId><ArticleId IdType="pubmed">16289240</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S, Tu Z, Liu Z, Fan N, Yang H, Yang S, et al. A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington&#x2019;s disease. Cell. 2018;173(4):989&#x2013;1002.e13. doi: 10.1016/j.cell.2018.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.005</ArticleId><ArticleId IdType="pmc">PMC5935586</ArticleId><ArticleId IdType="pubmed">29606351</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AHV. Mitochondrial defect in Huntington&#x2019;s disease caudate nucleus. Ann Neurol. 1996;39(3):385&#x2013;389. doi: 10.1002/ana.410390317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390317</ArticleId><ArticleId IdType="pubmed">8602759</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MMK, et al. Oxidative damage and metabolic dysfunction in huntington&#x2019;s disease: selective vulnerability of the basal ganglia. Ann Neurol. 1997;41(5):646&#x2013;653. doi: 10.1002/ana.410410514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410410514</ArticleId><ArticleId IdType="pubmed">9153527</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeira MH, Boia R, Santos PF, Ambr&#xf3;sio AF, Santiago AR. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm. 2015;2015:673090. doi: 10.1155/2015/673090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/673090</ArticleId><ArticleId IdType="pmc">PMC4385698</ArticleId><ArticleId IdType="pubmed">25873768</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CH, Fernandes R, Santiago AR, Ambr&#xf3;sio AF. Microglia contribution to the regulation of the retinal and choroidal vasculature in age-related macular degeneration. Cells. 2020;9(5):1217. doi: 10.3390/cells9051217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051217</ArticleId><ArticleId IdType="pmc">PMC7290930</ArticleId><ArticleId IdType="pubmed">32423062</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinha CVL, Cachulo ML, Alves D, Pires I, Marques JP, Barreto P, et al. Incidence of age-related macular degeneration in the central region of Portugal: the Coimbra eye study&#x2014;report 5. Ophthalmic Res. 2019;61(4):226&#x2013;235. doi: 10.1159/000496393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000496393</ArticleId><ArticleId IdType="pubmed">30820012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cachulo MDL, Lobo C, Figueira J, Ribeiro L, La&#xed;ns I, Vieira A, et al. Prevalence of age-related macular degeneration in Portugal: the Coimbra eye study&#x2014;report 1. Ophthalmologica. 2015;233:119&#x2013;127. doi: 10.1159/000371584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371584</ArticleId><ArticleId IdType="pubmed">25677077</ArticleId></ArticleIdList></Reference><Reference><Citation>Karunadharma PP, Nordgaard CL, Olsen TW, Ferrington DA. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Investig Ophthalmol Vis Sci. 2010;51(11):5470&#x2013;5479. doi: 10.1167/iovs.10-5429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.10-5429</ArticleId><ArticleId IdType="pmc">PMC3061495</ArticleId><ArticleId IdType="pubmed">20505194</ArticleId></ArticleIdList></Reference><Reference><Citation>Felszeghy S, Viiri J, Paterno JJ, Hyttinen JMT, Koskela A, Chen M, et al. Loss of NRF-2 and PGC-1&#x3b1; genes leads to retinal pigment epithelium damage resembling dry age-related macular degeneration. Redox Biol. 2019;20:1&#x2013;12. doi: 10.1016/j.redox.2018.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.09.011</ArticleId><ArticleId IdType="pmc">PMC6156745</ArticleId><ArticleId IdType="pubmed">30253279</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Y&#xfc;cel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18(2):110&#x2013;114. doi: 10.1097/ICU.0b013e3280895aea.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICU.0b013e3280895aea</ArticleId><ArticleId IdType="pubmed">17301611</ArticleId></ArticleIdList></Reference><Reference><Citation>Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081&#x2013;2090. doi: 10.1016/j.ophtha.2014.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2014.05.013</ArticleId><ArticleId IdType="pubmed">24974815</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711&#x2013;1720. doi: 10.1016/S0140-6736(04)16257-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)16257-0</ArticleId><ArticleId IdType="pubmed">15158634</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression. Evidence-Based Eye Care. 2003;4(3):137&#x2013;139. doi: 10.1097/00132578-200307000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00132578-200307000-00009</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, Noh YH, et al. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis. 2011;2(12):1&#x2013;10. doi: 10.1038/cddis.2011.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2011.117</ArticleId><ArticleId IdType="pmc">PMC3252734</ArticleId><ArticleId IdType="pubmed">22158479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Dai Y, Sun X. Parkin overexpression protects retinal ganglion cells against glutamate excitotoxicity. Mol Vis. 2017;23:447&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5524269</ArticleId><ArticleId IdType="pubmed">28761318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyshova K, Inoue K, Yamashita S-I, Fukuchi T, Kanki T. Glaucoma-associated mutations in the optineurin gene have limited impact on parkin-dependent mitophagy. Invest Opthalmol Vis Sci. 2019;60(10):3625. doi: 10.1167/iovs.19-27184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.19-27184</ArticleId><ArticleId IdType="pubmed">31469402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong YC, Holzbaur ELF. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci USA. 2014;111(42):4439&#x2013;4448. doi: 10.1073/pnas.1405752111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405752111</ArticleId><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol. 2004;56(3):336&#x2013;341. doi: 10.1002/ana.20256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20256</ArticleId><ArticleId IdType="pubmed">15349860</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouton-Liger F, Rosazza T, Sepulveda-Diaz J, Ieang A, Hassoun SM, Claire E, et al. Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop. Glia. 2018;66:1736&#x2013;1751. doi: 10.1002/glia.23337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23337</ArticleId><ArticleId IdType="pmc">PMC6190839</ArticleId><ArticleId IdType="pubmed">29665074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD, et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature. 2018;561(7722):258&#x2013;262. doi: 10.1038/s41586-018-0448-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0448-9</ArticleId><ArticleId IdType="pmc">PMC7362342</ArticleId><ArticleId IdType="pubmed">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Byun J-W, Choi I, Kim B, Jeong H-K, Jou I, et al. PINK1 deficiency enhances inflammatory cytokine release from acutely prepared brain slices. Exp Neurobiol. 2013;22(1):38. doi: 10.5607/en.2013.22.1.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2013.22.1.38</ArticleId><ArticleId IdType="pmc">PMC3620457</ArticleId><ArticleId IdType="pubmed">23585721</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriya S, Tan VP, Yee AK, Parhar IS. pink1, atp13a2 and uchl1 expressions are affected by inflammation in the brain. Neurosci Lett. 2019;708:134330. doi: 10.1016/j.neulet.2019.134330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134330</ArticleId><ArticleId IdType="pubmed">31201839</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429(6990):417&#x2013;423. doi: 10.1038/nature02517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02517</ArticleId><ArticleId IdType="pubmed">15164064</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Sun L, Chen ZJ. Regulation and function of the cGAS&#x2013;STING pathway of cytosolic DNA sensing. Nat Immunol. 2016;17(10):1142&#x2013;1149. doi: 10.1038/ni.3558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3558</ArticleId><ArticleId IdType="pubmed">27648547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerur N, Fukuda S, Banerjee D, Kim Y, Fu D, Apicella I, et al. CGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat Med. 2018;24(1):50&#x2013;61. doi: 10.1038/nm.4450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4450</ArticleId><ArticleId IdType="pmc">PMC5760363</ArticleId><ArticleId IdType="pubmed">29176737</ArticleId></ArticleIdList></Reference><Reference><Citation>West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520(7548):553&#x2013;557. doi: 10.1038/nature14156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14156</ArticleId><ArticleId IdType="pmc">PMC4409480</ArticleId><ArticleId IdType="pubmed">25642965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JJ, Andreazza S, Whitworth AJ. The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models. Sci Rep. 2020;10(1):2693. doi: 10.1038/s41598-020-59647-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-59647-3</ArticleId><ArticleId IdType="pmc">PMC7021792</ArticleId><ArticleId IdType="pubmed">32060339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkirtzimanaki K, Kabrani E, Nikoleri D, Polyzos A, Blanas A, Sidiropoulos P, et al. IFN&#x3b1; impairs autophagic degradation of mtDNA promoting autoreactivity of SLE monocytes in a STING-dependent fashion. Cell Rep. 2018;25(4):921-933.e5. doi: 10.1016/j.celrep.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.09.001</ArticleId><ArticleId IdType="pmc">PMC6218203</ArticleId><ArticleId IdType="pubmed">30355498</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank-Cannon TC, Tran T, Ruhn KA, Martinez TN, Hong J, Marvin M, et al. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci. 2008;28(43):10825&#x2013;10834. doi: 10.1523/JNEUROSCI.3001-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3001-08.2008</ArticleId><ArticleId IdType="pmc">PMC2603252</ArticleId><ArticleId IdType="pubmed">18945890</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelmus MMM, Van Der Pol SMA, Jansen Q, Witte ME, Van Der Valk P, Rozemuller AJM, et al. Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions. Free Radic Biol Med. 2011;50(3):469&#x2013;476. doi: 10.1016/j.freeradbiomed.2010.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.11.033</ArticleId><ArticleId IdType="pubmed">21145388</ArticleId></ArticleIdList></Reference><Reference><Citation>Witte ME, Bol JGJM, Gerritsen WH, van der Valk P, Drukarch B, van Horssen J, et al. Parkinson&#x2019;s disease-associated parkin colocalizes with Alzheimer&#x2019;s disease and multiple sclerosis brain lesions. Neurobiol Dis. 2009;36(3):445&#x2013;452. doi: 10.1016/j.nbd.2009.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.08.009</ArticleId><ArticleId IdType="pubmed">19716418</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Shen R, Agnihotri SK, Chen Y, Huang Z, B&#xfc;eler H. Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death. Sci Rep. 2018;8(1):383. doi: 10.1038/s41598-017-18786-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18786-w</ArticleId><ArticleId IdType="pmc">PMC5762685</ArticleId><ArticleId IdType="pubmed">29321620</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi I, Kim J, Jeong HK, Kim B, Jou I, Park M, et al. PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR. Glia. 2013;61(5):800&#x2013;812. doi: 10.1002/glia.22475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22475</ArticleId><ArticleId IdType="pmc">PMC3657120</ArticleId><ArticleId IdType="pubmed">23440919</ArticleId></ArticleIdList></Reference><Reference><Citation>Dion&#xed;sio PEA, Oliveira SR, Amaral JSJD, Rodrigues CMP. Loss of microglial parkin inhibits necroptosis and contributes to neuroinflammation. Mol Neurobiol. 2018;63(4):2990&#x2013;3004. doi: 10.1007/s12035-018-1264-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1264-9</ArticleId><ArticleId IdType="pubmed">30074231</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TA, Nguyen AD, Chang J, Goldberg MS, Lee JK, Tansey MG. Lipopolysaccharide and tumor necrosis factor regulate parkin expression via Nuclear factor-kappa B. PLoS ONE. 2011;6(8):e23660. doi: 10.1371/journal.pone.0023660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023660</ArticleId><ArticleId IdType="pmc">PMC3157435</ArticleId><ArticleId IdType="pubmed">21858193</ArticleId></ArticleIdList></Reference><Reference><Citation>de L&#xe9;s&#xe9;leuc L, Orlova M, Cobat A, Girard M, Huong NT, Ba NN, et al. PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages. PLoS Negl Trop Dis. 2013;7(1):e2015. doi: 10.1371/journal.pntd.0002015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002015</ArticleId><ArticleId IdType="pmc">PMC3547867</ArticleId><ArticleId IdType="pubmed">23350010</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CH, Wijnholds J (2018) AAV-mediated gene therapy for CRB1-hereditary retinopathies. Intechopen 6:1&#x2013;20</Citation></Reference><Reference><Citation>Bian M, Liu J, Hong X, Yu M, Huang Y, Sheng Z, et al. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. PLoS ONE. 2012;7(6):e39953. doi: 10.1371/journal.pone.0039953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039953</ArticleId><ArticleId IdType="pmc">PMC3390003</ArticleId><ArticleId IdType="pubmed">22792139</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskal N, Riccio V, Bashkurov M, Taddese R, Datti A, Lewis PN, et al. ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway. Nat Commun. 2020;11(1):1&#x2013;14. doi: 10.1038/s41467-019-13781-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13781-3</ArticleId><ArticleId IdType="pmc">PMC6941965</ArticleId><ArticleId IdType="pubmed">31900402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhang T, Ge X, Chen J, Zhao Y, Fu J. Parkin overexpression attenuates A&#x3b2;-induced mitochondrial dysfunction in HEK293 cells by restoring impaired mitophagy. Life Sci. 2020;244:117322. doi: 10.1016/j.lfs.2020.117322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117322</ArticleId><ArticleId IdType="pubmed">31958419</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong X, Liu J, Zhu G, Zhuang YH, Suo H, Wang P, et al. Parkin overexpression ameliorates hippocampal long-term potentiation and &#x3b2;-amyloid load in an Alzheimer&#x2019;s disease mouse model. Hum Mol Genet. 2014;23(4):1056&#x2013;1072. doi: 10.1093/hmg/ddt501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt501</ArticleId><ArticleId IdType="pubmed">24105468</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>